It was found that SNHG4 expression was significantly increased in oxaliplatin-resistant CRC cells compared to non-resistant cells, and mechanistic studies suggest that overexpressed SNHG4 decreases mRNA stability in tumor cells by targeting PTEN, thereby inhibiting ferroptosis and promoting oxaliplatin resistance [170]. This evidence concerns the gene SNHG4 and neoplasm.